SI1354873T1 - Salt of perindopril and pharmaceutical compositions containing it - Google Patents

Salt of perindopril and pharmaceutical compositions containing it

Info

Publication number: SI1354873T1
Authority: SI; Slovenia
Prior art keywords: perindopril; salt; pharmaceutical compositions; compositions containing; pharmaceutical
Prior art date: 2002-04-18

Application number

SI200330002T

Other languages

English (en)

Slovenian (sl)

Inventor

Gerard Damien

Francois Lefoulon

Bernard Marchand

Original Assignee

Les Laboratoires Servier

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-18

Filing date

2003-02-17

Publication date

2004-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8871521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1354873(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-02-17 Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier

2004-12-31 Publication of SI1354873T1 publication Critical patent/SI1354873T1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Heart & Thoracic Surgery (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Hospice & Palliative Care (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Indole Compounds (AREA)
Peptides Or Proteins (AREA)

SI200330002T 2002-04-18 2003-02-17 Salt of perindopril and pharmaceutical compositions containing it SI1354873T1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0204847A FR2838648B1 (fr)	2002-04-18	2002-04-18	Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
EP03290383A EP1354873B1 (fr)	2002-04-18	2003-02-17	Sel de périndopril et les compositions pharmaceutiques qui le contiennent

Publications (1)

Publication Number	Publication Date
SI1354873T1 true SI1354873T1 (en)	2004-12-31

Family

ID=8871521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200330002T SI1354873T1 (en)	2002-04-18	2003-02-17	Salt of perindopril and pharmaceutical compositions containing it

Country Status (38)

Country	Link
US (1)	US6696481B2 (xx)
EP (1)	EP1354873B1 (xx)
JP (1)	JP3737488B2 (xx)
KR (1)	KR100542468B1 (xx)
CN (1)	CN1211365C (xx)
AP (1)	AP1787A (xx)
AR (1)	AR039428A1 (xx)
AT (1)	ATE271036T1 (xx)
AU (2)	AU2003222921A1 (xx)
BR (1)	BR0300709A (xx)
CA (1)	CA2423825C (xx)
CR (1)	CR7576A (xx)
DE (1)	DE60300011T2 (xx)
DK (1)	DK1354873T3 (xx)
EA (1)	EA005676B1 (xx)
EC (1)	ECSP045441A (xx)
ES (1)	ES2224092T3 (xx)
FR (1)	FR2838648B1 (xx)
GE (1)	GEP20074211B (xx)
HK (1)	HK1057367A1 (xx)
HR (1)	HRP20041079B1 (xx)
IL (1)	IL164424A (xx)
IS (1)	IS2842B (xx)
MA (1)	MA27115A1 (xx)
ME (1)	ME00454B (xx)
MX (1)	MXPA03002346A (xx)
NO (1)	NO324323B1 (xx)
NZ (1)	NZ524478A (xx)
OA (1)	OA12806A (xx)
PL (1)	PL359321A1 (xx)
PT (1)	PT1354873E (xx)
RS (1)	RS51694B (xx)
SI (1)	SI1354873T1 (xx)
TN (1)	TNSN04206A1 (xx)
TR (1)	TR200401793T4 (xx)
UA (1)	UA79463C2 (xx)
WO (1)	WO2003087050A2 (xx)
ZA (1)	ZA200301395B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2395195A (en) *	2002-11-18	2004-05-19	Cipla Ltd	Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
HUE031058T2 (en) *	2004-03-29	2017-06-28	Servier Lab	A method of producing a solid pharmaceutical composition
SI21800A (sl)	2004-05-14	2005-12-31	Krka, Tovarna Zdravil, D.D., Novo Mesto	Nov postopek sinteze perindoprila
PT1679072E (pt) *	2005-01-06	2008-12-22	Ipca Lab Ltd	Processo para a síntese de derivados de ácido (2s,3as,7as)-1-(s)-alanil-octa-hidro-1h-indole-2-carboxílico e utilização na síntese de perindopril
EA012420B1 (ru) *	2005-03-14	2009-10-30	Ле Лаборатуар Сервье	Улучшенный способ очистки периндоприла
FR2894825B1 (fr) *	2005-12-21	2010-12-03	Servier Lab	Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) *	2006-02-28	2008-04-18	Servier Lab	Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr) *	2006-02-28	2008-04-18	Servier Lab	Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
GB0624087D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril combination salt
GB0624090D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril amine salts
GB0624084D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril amino acid salts
SI22542A (sl) *	2007-06-04	2008-12-31	Diagen D.O.O.	Stabilna formulacija amorfnih soli perindoprila, postopek za njeno pripravo v industrijskem merilu in njena uporaba za zdravljenje hipertenzije
PL2318365T3 (pl)	2008-06-24	2016-02-29	Mylan Laboratories Ltd	Nowe odmiany polimorficzne (L) argininianu peryndoprylu i sposoby ich wytwarzania
AU2009212902A1 (en) *	2008-09-03	2010-03-18	Apotex Pharmachem Inc.	Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
CN101766598A (zh) *	2008-12-31	2010-07-07	东英（江苏）药业有限公司	含有培哚普利的药物组合物
GB0910692D0 (en) *	2009-06-20	2009-08-05	Teva Pharma	Compound
SI23149A (sl)	2009-09-21	2011-03-31	Silverstone Pharma	Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
FR2961105B1 (fr) *	2010-06-15	2013-02-08	Servier Lab	Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
FR2985511B1 (fr)	2012-01-05	2014-01-03	Servier Lab	Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2985512B1 (fr)	2012-01-05	2014-06-20	Servier Lab	Procede de preparation du sel de l-arginine du perindopril
CN103172696B (zh) *	2012-12-19	2014-12-17	宁波美诺华药业股份有限公司	一种γ晶型的培哚普利精氨酸盐的制备方法
FR3040303B1 (fr) *	2015-08-27	2019-04-05	Les Laboratoires Servier Suivi Par Sabine Goudeau-Wenger	Composition pharmaceutique comprenant un inhibiteur de la hmg-coa reductase et un inhibiteur eca
FR3050380B1 (fr)	2016-04-20	2020-07-10	Les Laboratoires Servier	Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
EP3842035A1 (en)	2019-12-23	2021-06-30	KRKA, d.d., Novo mesto	Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl)	2021-11-18	2023-05-31	Zupet Rok	Postopek za pripravo hidratirane oblike perindopril l-arginina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2503155A2 (fr) *	1980-10-02	1982-10-08	Science Union & Cie	Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2811320B1 (fr) *	2000-07-06	2002-08-23	Adir	Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

2002
- 2002-04-18 FR FR0204847A patent/FR2838648B1/fr not_active Expired - Lifetime
2003
- 2003-02-17 ES ES03290383T patent/ES2224092T3/es not_active Expired - Lifetime
- 2003-02-17 GE GEAP8501A patent/GEP20074211B/en unknown
- 2003-02-17 DK DK03290383T patent/DK1354873T3/da active
- 2003-02-17 AT AT03290383T patent/ATE271036T1/de active
- 2003-02-17 OA OA1200400279A patent/OA12806A/en unknown
- 2003-02-17 WO PCT/FR2003/000507 patent/WO2003087050A2/fr active Application Filing
- 2003-02-17 DE DE60300011T patent/DE60300011T2/de not_active Expired - Lifetime
- 2003-02-17 RS YU90904A patent/RS51694B/en unknown
- 2003-02-17 PT PT03290383T patent/PT1354873E/pt unknown
- 2003-02-17 SI SI200330002T patent/SI1354873T1/xx unknown
- 2003-02-17 TR TR2004/01793T patent/TR200401793T4/xx unknown
- 2003-02-17 AU AU2003222921A patent/AU2003222921A1/en not_active Abandoned
- 2003-02-17 UA UA20041109440A patent/UA79463C2/uk unknown
- 2003-02-17 ME MEP-2008-688A patent/ME00454B/me unknown
- 2003-02-17 EP EP03290383A patent/EP1354873B1/fr not_active Expired - Lifetime
- 2003-02-17 AP APAP/P/2004/003154A patent/AP1787A/en active
- 2003-02-20 ZA ZA200301395A patent/ZA200301395B/xx unknown
- 2003-02-21 US US10/371,865 patent/US6696481B2/en not_active Expired - Lifetime
- 2003-02-24 NO NO20030849A patent/NO324323B1/no not_active IP Right Cessation
- 2003-02-27 AU AU2003200700A patent/AU2003200700C1/en not_active Revoked
- 2003-02-28 NZ NZ524478A patent/NZ524478A/en not_active IP Right Cessation
- 2003-03-07 CN CNB031071481A patent/CN1211365C/zh not_active Expired - Lifetime
- 2003-03-18 MX MXPA03002346A patent/MXPA03002346A/es active IP Right Grant
- 2003-03-20 KR KR1020030017434A patent/KR100542468B1/ko active IP Right Grant
- 2003-03-21 BR BR0300709-0A patent/BR0300709A/pt not_active Application Discontinuation
- 2003-03-24 PL PL03359321A patent/PL359321A1/xx not_active Application Discontinuation
- 2003-03-25 JP JP2003083250A patent/JP3737488B2/ja not_active Expired - Lifetime
- 2003-04-03 EA EA200300334A patent/EA005676B1/ru unknown
- 2003-04-03 CA CA002423825A patent/CA2423825C/fr not_active Expired - Fee Related
- 2003-04-16 AR ARP030101332A patent/AR039428A1/es not_active Application Discontinuation
2004
- 2004-01-10 HK HK04100189A patent/HK1057367A1/xx not_active IP Right Cessation
- 2004-10-05 IL IL164424A patent/IL164424A/en active IP Right Grant
- 2004-10-15 TN TNP2004000206A patent/TNSN04206A1/en unknown
- 2004-10-27 IS IS7516A patent/IS2842B/is unknown
- 2004-11-03 MA MA27926A patent/MA27115A1/fr unknown
- 2004-11-17 HR HRP20041079AA patent/HRP20041079B1/hr not_active IP Right Cessation
- 2004-11-18 CR CR7576A patent/CR7576A/es unknown
- 2004-11-18 EC EC2004005441A patent/ECSP045441A/es unknown

Also Published As

Publication number	Publication date
EA005676B1 (ru)	2005-04-28
IS7516A (is)	2004-10-27
IL164424A0 (en)	2005-12-18
ES2224092T3 (es)	2005-03-01
WO2003087050A2 (fr)	2003-10-23
AU2003222921A1 (en)	2003-10-27
DE60300011T2 (de)	2005-03-17
HRP20041079B1 (hr)	2013-04-30
US20030199568A1 (en)	2003-10-23
MA27115A1 (fr)	2004-12-20
AU2003200700C1 (en)	2015-04-23
UA79463C2 (en)	2007-06-25
WO2003087050A3 (fr)	2004-03-25
NZ524478A (en)	2004-05-28
NO20030849D0 (no)	2003-02-24
AP1787A (en)	2007-10-04
ECSP045441A (es)	2005-03-10
HRP20041079A2 (en)	2004-12-31
AR039428A1 (es)	2005-02-16
TR200401793T4 (tr)	2004-08-23
BR0300709A (pt)	2004-09-08
CN1211365C (zh)	2005-07-20
RS90904A (xx)	2007-02-05
MXPA03002346A (es)	2005-08-26
US6696481B2 (en)	2004-02-24
ATE271036T1 (de)	2004-07-15
OA12806A (en)	2006-07-11
JP2003321493A (ja)	2003-11-11
DE60300011D1 (de)	2004-08-19
RS51694B (en)	2011-10-31
CR7576A (es)	2008-08-21
CA2423825A1 (fr)	2003-10-18
PT1354873E (pt)	2004-10-29
TNSN04206A1 (en)	2007-03-12
EP1354873A1 (fr)	2003-10-22
CA2423825C (fr)	2006-02-21
ME00454B (me)	2011-10-10
NO20030849L (no)	2003-10-20
AU2003200700B2 (en)	2005-01-20
PL359321A1 (en)	2003-10-20
HK1057367A1 (en)	2004-04-02
FR2838648B1 (fr)	2004-05-21
JP3737488B2 (ja)	2006-01-18
IS2842B (is)	2013-08-15
ZA200301395B (en)	2003-09-02
DK1354873T3 (da)	2004-11-01
NO324323B1 (no)	2007-09-24
AU2003222921A8 (en)	2003-10-27
KR100542468B1 (ko)	2006-01-11
AU2003200700A1 (en)	2003-11-06
KR20030082902A (ko)	2003-10-23
FR2838648A1 (fr)	2003-10-24
EA200300334A1 (ru)	2003-12-25
AP2004003154A0 (en)	2004-12-31
GEP20074211B (en)	2007-10-10
EP1354873B1 (fr)	2004-07-14
CN1451656A (zh)	2003-10-29
IL164424A (en)	2010-12-30

Publication	Publication Date	Title
SI1354873T1 (en)	2004-12-31	Salt of perindopril and pharmaceutical compositions containing it
IL173930A0 (en)	2006-07-05	Pharmaceutical compositions containing forms of r-baclofen
IL164185A0 (en)	2005-12-18	Pharmaceutical compositions containing trifluoromethylphenyl amide derivatives
HUP0401711A3 (en)	2009-07-28	N-heterocyclic inhibitors of tnf-alpha and pharmaceutical compositions containing them
IL164987A0 (en)	2005-12-18	Proline derivatives and pharmaceutical compositions containing
IL166108A0 (en)	2006-01-15	Novel compounds pharmaceutical compositions containing same and methods of use for same
HUP0400974A3 (en)	2012-09-28	Peptide-based compounds and pharmaceutical compositions containing them
PL375860A1 (en)	2005-12-12	Benzodiazepine derivatives and pharmaceutical compositions containing them
IL163931A (en)	2013-06-27	Derivatives of Tetrazycline Compounds Converted by Amino Methyl and Pharmaceutical Preparation Containing Them
HUP0401656A3 (en)	2012-05-02	Mch antagonists for the treatment of obesity and pharmaceutical compositions containing them
HK1086485A1 (en)	2006-09-22	Novel compounds, pharmaceutical compositions containing same, and methods of use for same
IL164022A0 (en)	2005-12-18	Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same
IL166621A0 (en)	2006-01-15	Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
IL163868A (en)	2011-11-30	Hemiasterlin derivatives and pharmaceutical compositions comprising them
IL176077A0 (en)	2006-10-05	1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
IL170313A (en)	2010-11-30	Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
ZA200508204B (en)	2007-03-28	Pharmaceutical composition of atorvastatin
IL165902A0 (en)	2006-01-15	Magnesium salt of panroprazole and its hydrates and pharmaceutical compositions containing the same
PL361518A1 (en)	2004-02-09	Application of substance and pharmaceutical composition
IL163959A (en)	2010-12-30	Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them
HK1076743A1 (en)	2006-01-27	Orodispersible pharmaceutical composition comprising perindopril
HK1080449A1 (zh)	2006-04-28	抗炎劑的十六烷基吡啶鹽以及含有該鹽的藥物組合物
HUP0401712A3 (en)	2009-06-29	N-heterocyclic inhibitors of tnf-alpha and pharmaceutical compositions containing them
AU2003295713A8 (en)	2004-06-15	Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
AU2003291458A8 (en)	2004-06-03	Pharmaceutical compositions and methods of using taxane derivatives